Characterization of Potassium Channels in the Human Parasite Trypanosoma Cruzi
Characterization of Potassium Channels in the Human Parasite Trypanosoma Cruzi
批准号:
8703605
负责人:
Veronica Jimenez
金额:
$24.42万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-18 至 2016-12-31
关键词:
AblationBenznidazoleBlood CirculationCalcium-Activated Potassium ChannelCell Proliferation RegulationCell membraneCell physiologyCellsChagas DiseaseComplementComplexCongestive Heart FailureDiseaseElectrodesEnvironmentEpidemiologyFDA approvedFecesFinancial compensationHeart DiseasesHomologous GeneHumanImmigrationImmunofluorescence ImmunologicInsect VectorsInsectaIon ChannelIonsKidneyKnock-outLaboratoriesLatin AmericaLifeLife Cycle StagesLightLipidsLiposomesMaintenanceMembraneMembrane PotentialsModificationMolecularMolecular ProfilingNifurtimoxOocytesOsmolar ConcentrationOsmoregulationParasitesPathologyPharmaceutical PreparationsPhysiologicalPlayPotassium ChannelPovertyProcessPropertyProteinsRegulationRoleSiteSite-Directed MutagenesisStagingStressTrypanosoma cruziUrineWorkXenopus laevisabstractingcellular imagingcopingenvironmental changeextracellulargenetic manipulationgutted vectorin vivoinward rectifier potassium channelmitochondrial membranenew therapeutic targetoverexpressionpatch clampreconstitutionresponserural areasuccesstherapeutic targetvectorvoltage clamp
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Chagas disease is a zoonotic tropical pathology, caused by the protozoan parasite Trypanosoma cruzi.
Endemic en Latin America, it is one of the leading causes of congestive heart failure in the world. Historically
associated with poverty in rural areas, immigration and relocation of the vectors are changing the epidemiology
of the disease, as evidenced by a substantial increase in the number of cases in the US. Treatment is
restricted to nifurtimox and benznidazole, both of which are relatively toxic, have limited efficacy and are not
approved by the FDA. Our laboratory has been working on the rational search for chemotherapeutic treatments
for Chagas disease that can selectively target the parasite without compromising human cells. Ion channels
are potential targets for selective drugs against a broad range of diseases because they are responsible for
essential cellular functions like plasma membrane and mitochondrial membrane potential maintenance, pH
regulation, cell proliferation, and adaptation to environmental changes including osmoregulation. During its life
cycle, the parasite encounters extreme fluctuations in ionic concentrations, osmolarities and pHs.
Previous studies in our laboratory suggested that in T. cruzi, K+ channels are important components of the
regulatory mechanisms that maintain the plasma membrane potential, intracellular pH and osmolarity. It has
also been demonstrated that trypomastigotes, the infective forms of the parasite, are particularly sensitive to
changes in extracellular K+ concentration while epimastigotes and amastigotes are less responsive to this ion.
In T. cruzi, we have identified sequences encoding for putative inward rectifier (TcKir) and calcium-activated K+
channels (TcCAKC). They have conserved functional domains, but limited identity with human homologs
(<15%) making them potential selective pharmacological targets against the parasite. We propose that ion
channels play an important role in sensing and adaptation to environmental conditions in T. cruzi. We propose
that different types of K+ channels integrate a homeostatic network that allows the parasite to detect and
respond to changes in osmotic and ionic conditions. Fundamental processes like differentiation and invasion
can be regulated by modification of the ionic concentrations determining the success of the parasite in infecting
new hosts. Analysis of T. cruzi potassium channels expression profiles and localization, complemented with
electrophysiological studies will shed light about how these proteins work. Genetic manipulation of the level of
expression and phenotypic analysis in vivo will demonstrate the physiological role of potassium channels in the
parasite and will help to establish their potential as therapeutic targets.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.phymed.2014.06.005
发表时间:
2014-09-25
期刊:
PHYTOMEDICINE
影响因子:
7.9
作者:
[Jimenez, V., Kemmerling, U., Galanti, N.]
通讯作者:
Galanti, N.
Identification and function of mechanosensitive channels in Trypanosoma cruzi
-
批准号:10730514
-
项目类别:
-
资助金额:$41.66万
-
财政年份:2016
-
负责人:Veronica Jimenez
-
依托单位:
Identification and function of mechanosensitive channels in Trypanosoma cruzi
-
批准号:9232858
-
项目类别:
-
资助金额:$40.48万
-
财政年份:2016
-
负责人:Veronica Jimenez
-
依托单位:
Characterization of Potassium Channels in the Human Parasite Trypanosoma Cruzi
-
批准号:8665023
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2013
-
负责人:Veronica Jimenez
-
依托单位:
Characterization of potassium channels in the human parasite Trypanosoma cruzi
-
批准号:8353272
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2012
-
负责人:Veronica Jimenez
-
依托单位:
海外基金